Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. - Wikidata - wikimedia - TriplyDB

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

http://www.wikidata.org/entity/Q33722630

about

Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia Humanized hemato-lymphoid system mice Cancer stem cell targeted therapy: progress amid controversies.Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia Hedgehog Signaling in the Maintenance of Cancer Stem Cells Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Life history trade-offs in cancer evolution Tumour heterogeneity and cancer cell plasticity Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity.Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.The therapeutic implications of plasticity of the cancer stem cell phenotype.Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia.Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.From single cells to deep phenotypes in cancer.The mammary cellular hierarchy and breast cancer.Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia.Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.Human cancer growth and therapy in immunodeficient mouse models.High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.Cancer stem cells: impact, heterogeneity, and uncertainty A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia Prostate cancer stem cell biology.High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy.Acute myeloid leukemia stem cells and CD33-targeted immunotherapy Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

P2860

Q26765858-674A7CF7-98D4-4804-B3E7-DDC90DF5592D Q26771440-9DB46400-2E8A-4148-87FB-95B619911A7B Q26779931-453182BE-30A2-4CB7-8024-CD7B72C1922E Q26796514-BC11A094-F3C2-4361-9C1C-528577EA2264 Q26798191-E56D1BA1-A467-4CA3-8A19-DFE898F90817 Q26849792-4DEF8038-2F03-45BB-9D06-584995E9758A Q27853019-4779981E-E1AF-4313-AB38-B7880AB5AEAF Q28071384-F39A2200-3AC4-4581-B88D-736EF9DFF8D8 Q28081844-7F766B63-C817-4472-BC92-C3D731459792 Q28657962-8CBB9331-B477-4FC7-958B-7B7B96D08B9E Q29617990-8E39DB6F-DA2A-4207-BB7C-F9B2BF5C9A56 Q30244186-72F6FE41-70CB-4449-BE33-23B8780D7A04 Q30975629-93AEA8A7-B141-422B-83AF-974C89EC0300 Q33409425-D271AD41-F03A-44B2-A618-E9AE33C52A6D Q33558141-8A6B2491-C10E-421C-873C-E5B646E3693E Q33686199-8C93B965-4365-445E-B563-C7AFFB3803F7 Q33711497-BB400E4C-579C-4FB8-9ABC-308D3A3DC427 Q33778409-26EEADA7-F8DD-477C-A05B-58D718A4C64D Q33806096-4A949A75-A491-4CA4-BCED-7E218F55F9F3 Q33873844-1B07B147-B3FA-4553-B863-A0FCBDE6ED85 Q34207336-9AB47F9A-9281-4FCB-8D6C-F2CDC6B538AA Q34260622-5F7A20BB-2E0C-4546-9BFF-D6DDF5E04B29 Q34287095-338A25F5-7CD5-4B95-8AAF-2EED40196C1F Q34396558-2A71F2C9-AE23-4725-8A4B-FB7B0B7884C3 Q34428887-F6828812-6467-43A4-A6B7-008B4624C724 Q34720554-D7E2698F-F48B-4BDA-9A93-451E0F54A7C0 Q34905557-4339D247-F9BC-49BF-AEB5-5E59AA42A0AE Q35040064-4B73511D-2104-4703-92BA-C4474CA38483 Q35300118-97FC9920-A50C-4447-B90F-7D3782C6CA43 Q35348105-00EE0307-10D7-4A0D-8211-EE4EE78A99CC Q35391634-3AA010F3-6DD0-40B4-A11E-BB97C612D5C1 Q35545282-C2723674-6109-46FE-8B1F-3BAD8C4A109C Q35596914-D7DB8D2C-546C-4516-9044-3E88DF35B25F Q35857599-146C9ACE-D7F9-4809-AB57-B8C92F3A46CF Q35885317-AACCA699-D87D-4294-A906-9C1905F92A81 Q35903584-36A13349-599E-4D91-B832-062DAEC972C9 Q35988576-9489A7BF-005A-49DC-8B98-1FDBC35114F7 Q36058588-5F43F742-82F9-452C-8092-532E58137B2D Q36080036-CBF3D46F-B36B-4ACC-9414-3DEE5F2586BD Q36144842-945C6E32-04FB-42E7-ADA6-10C622D68EB4

P2860

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

http://www.wikidata.org/entity/Q33722630

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@ast

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@en

type

label

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@ast

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@en

prefLabel

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@ast

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@en

P1433

Q33722630-42DFAE27-14C5-44C4-8013-14F944413C84

P1476

Q33722630-B2DB5266-A0E7-442D-A8F4-7A7C8AD7F69C

P2093

Q33722630-187534F9-4211-4499-9777-B098BC5E7993

Q33722630-19C02EB1-1E59-4A16-8A42-AA367E22FD5D

Q33722630-2C6814CF-F064-4854-8689-B6FD492E7CD7

Q33722630-2D3E414D-C2F2-4BAC-BCBA-E60EC475321C

Q33722630-31C87EE8-4C8D-4705-B87B-D4319038F66D

Q33722630-424CA708-DF58-492D-895B-84979D3D71BC

Q33722630-79F827B3-FD3E-4D39-BEB5-8943EDC8ABB3

Q33722630-7BAFD1B1-D7DA-4960-8DDE-DE96A622F253

Q33722630-A16C15E4-F8F1-4281-811F-D4B8AF47733D

Q33722630-ADEF22CF-47E8-479E-86AC-8B180E07CDC8

P2860

Q33722630-22F04392-3867-48EE-8A27-45F8FD8153AB

Q33722630-2609D92C-3D2D-461F-A12E-112834927918

Q33722630-27BFABFB-2DAB-45F5-93BB-FA8A2D9A3A3F

Q33722630-2DFDE895-0A3A-4FA4-8CEE-387C9E04B31D

Q33722630-31C16173-3BA9-4290-8B09-7292BA38A2A1

Q33722630-3AC90F5E-BC68-490B-AB9F-DAA83B776726

Q33722630-3BA7FDC1-0BF6-4E9A-A9DB-C3F96FA3EBDE

Q33722630-3FC21AFA-906A-483B-A94F-876D34800797

Q33722630-5E69815E-4D04-4948-9664-CF70120CB1DF

Q33722630-5F24CFF6-9927-4D2C-A0B4-23BDFCE9C705

P304

Q33722630-D97F3DC1-D8C4-406B-8E20-574D0B58C240

P31

Q33722630-0450E87D-5FDC-4505-B30D-F518540B3BFD

P356

Q33722630-ADFE82A0-240C-49B3-B451-6B4744DDF99A

P407

Q33722630-0260D39D-F44F-4FB8-96F2-C30FD389C563

P433

Q33722630-A54EACF7-B8BE-48A8-80E9-FAC88CD412EF

P478

Q33722630-645D6687-BB62-4911-B14A-C95E353D8E5A

P50

Q33722630-B257E4A6-1889-4E2D-89A1-B9E51F1B7B11

P577

Q33722630-43B3217E-AE56-4985-9D54-8AEA306B3418

P5875

Q33722630-395F98D7-1FD7-4AB9-A0E4-EDF06C974953

P698

Q33722630-683A3A5F-677F-41F2-A219-9CC57AEA1B74

P921

Q33722630-2CEF0B10-34FE-4105-921F-05DE08A16008

Q33722630-8F8F8990-7D6D-46A3-A63D-A80E80E436D3

P932

Q33722630-7E6F77E4-86C8-46B5-9CAD-11AE2E10F1C9

P356

BLOOD-2009-02-206565

P1433

P1476

Leukemia-initiating cells from ...... eside in the CD34(-) fraction.

@en

P2093

David C Taussig

http://www.w3.org/2001/XMLSchema#string

Debra Lillington

http://www.w3.org/2001/XMLSchema#string

Dominique Bonnet

http://www.w3.org/2001/XMLSchema#string

Farideh Miraki-Moud

http://www.w3.org/2001/XMLSchema#string

Heather Oakervee

http://www.w3.org/2001/XMLSchema#string

Jacques Vargaftig

http://www.w3.org/2001/XMLSchema#string

Jamie Cavenagh

http://www.w3.org/2001/XMLSchema#string

John G Gribben

http://www.w3.org/2001/XMLSchema#string

Kirsty Sharrock

http://www.w3.org/2001/XMLSchema#string

Samir G Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Modeling the initiation and progression of human acute leukemia in mice

Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience.

P304

1976-1984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-02-206565

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Griessinger

P577

2010-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40869707

http://www.w3.org/2001/XMLSchema#string

P698

20053758

http://www.w3.org/2001/XMLSchema#string

P921

P932

2837317

http://www.w3.org/2001/XMLSchema#string